IDR Data
CMS PUF data · 2023 Q1–2025 Q4

Federal IDR outcomes: Internal and family medicine

In 2025 Q1–Q4, the provider or facility offer prevailed in 86.1% of 25,299 determined Federal IDR dispute line items for internal and family medicine. The median prevailing offer was 6.44x the QPA (25th–75th percentile 3.11x–10.73x; n = 24,590). The median time to a decision was 32 business days (n = 25,299).

Specialty group built from the CMS free-text specialty field; see the grouping rules.

Determined line items

25,299

2025 Q1–Q4 · 76 split decisions excluded

Provider win rate

86.1%

n = 25,299 · 2025 Q1–Q4

Median payment vs QPA

6.44x

middle half 3.11x–10.73x · n = 24,590 · 2025 Q1–Q4

Median days to decision

32

business days, from dispute initiation · n = 25,299 · 2025 Q1–Q4

Dollar amounts are not shown for specialty groups: the CMS QPA and Offers file, the only source of dollar figures, has no specialty field. See methodology.

By period

PeriodLine itemsWin %Median ×QPA25th–75thRatio nMedian days
2025 Q1–Q425,29986.1%6.44x3.11x–10.73x24,59032
2024 Q1–Q42,62076.3%8.37x2.45x–12.13x2,56439
2023 Q1–Q44575.6%3.97x2.82x–3.97x45141
2023 Q1–2025 Q427,96485.2%6.59x3.09x–10.98x27,199not pooled

Line items = determined dispute line items (n). Win rate excludes split decisions and includes default decisions. Ratio n = line items reporting a payment-to-QPA ratio. Days are business days as reported by CMS (2023–2024: from IDR entity assignment; 2025: from initiation) and are never pooled.

By state

State (place of service)Line itemsWin %Median ×QPARatio nMedian days
California6,12787.0%6.23x6,10027
Texas5,49193.7%5.48x5,02329
Missouri2,81179.2%7.86x2,80343
New York2,47282.3%10.23x2,46932
Arizona1,30977.6%8.27x1,30734
Maryland1,29889.8%7.14x1,29634
Indiana1,04285.8%6.80x88439.5
New Jersey72366.5%3.21x70029
Georgia61584.4%5.30x61444
Virginia27184.9%5.48x26947
Louisiana26873.9%9.14x26737
Oklahoma25897.7%10.85x25130
Florida25683.6%8.22x25652
Ohio22091.4%8.24x22027
New Mexico21698.1%9.67x21237
Nevada20886.1%5.30x20828.5
Tennessee19483.5%6.00x19484
Arkansas16874.4%6.36x16833.5
Montana15084.0%4.46x15044
Illinois13091.5%6.48x13065
Iowa12693.7%5.50x12527
Washington10592.4%3.61x10536
Kansas10493.3%8.68x10332.5
Oregon9474.5%2.34x9432
Michigan8895.5%5.76x8842.5
South Carolina8481.0%5.94x8436.5
Wyoming5294.2%2.62x5288
North Carolina5188.2%4.66x5137
Wisconsin4895.8%4.37x4823
Alabama4386.0%6.86x4340
Idaho4290.5%7.08x4218
Massachusetts4095.0%6.50x4024
Colorado3470.6%5.72x3427.5
West Virginia3497.1%11.65x3465

2025 Q1–Q4 · rows with n ≥ 30 determined line items · sorted by n.

Most disputed CPT codes

CPT codeLine itemsWin %Median ×QPARatio nMedian days
99233 Subsequent hospital care with moderate levelof medical decision making, if using4,97083.4%6.24x4,88333
99232 Subsequent hospital care with moderate levelof medical decision making, if using3,43184.0%7.16x3,25433
99223 Initial hospital care with moderate level of medical decision making, if using t3,30986.6%7.14x3,22731
99291 Critical care, first 30-74 minutes2,82889.2%5.76x2,80632
99239 Hospital discharge day management, more than 30 minutes2,66884.5%6.00x2,61033
99222 Initial hospital care with straightforward or low-level medical decision making,1,57287.4%5.21x1,53630
99238 Hospital discharge day management, 30 minutes or less80090.1%6.61x77327
93010 Routine electrocardiogram (ECG) using at least 12 leads with interpretation and 53391.7%7.49x52933
99284 Emergency department visit with moderate level of medical decision making31288.5%9.97x31240
99497 Advance care planning, first 30 minutes25582.0%5.87x25143
99285 Emergency department visit with high level of medical decision making25092.4%12.26x24437.5
99231 Subsequent hospital care with straightforward or low level of medical decision m24983.9%39.02x †24035
99235 Initial hospital care with same-day admission and discharge with moderate level 22690.3%2.95x22424
43239 Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscop22089.5%104.23x †21824
99236 Initial hospital care with same-day admission and discharge with high level of m21787.6%2.04x21627
45380 Biopsy of large bowel using a flexible endoscope14189.4%60.41x †13825
99418 Prolonged inpatient or observation service, each 15 minutes of total time beyond13488.8%1.00x13436.5
99283 Emergency department visit with low level of medical decision making12983.7%13.85x12930
99292 Critical care, each additional 30 minutes10989.9%5.56x10937
99221 Initial hospital care with straightforward or low level of medical decision maki8583.5%11.28x8531
45385 Removal of polyps or growths of large bowel using an endoscope with mechanical s7188.7%41.90x †7126
31500 Emergent insertion of breathing tube into windpipe using an endoscope6885.3%5.93x6837
36556 Insertion of non-tunneled central venous tube for infusion (5 years or older)6888.2%5.02x6750
00840 Anesthesia for other procedure on lower abdomen5286.5%4.94x5224.5
45378 Diagnostic exam of large bowel using a flexible endoscope4680.4%59.48x †4626

2025 Q1–Q4 · rows with n ≥ 30 determined line items · sorted by n.

FAQ

What is the Federal IDR provider win rate for internal and family medicine?

In 2025 Q1–Q4, the provider or facility offer was selected in 86.1% of 25,299 determined dispute line items for internal and family medicine. Split decisions are excluded from the denominator and default decisions are included. Withdrawn, settled and ineligible disputes are not in the CMS data.

How do Federal IDR payments compare with the QPA for internal and family medicine?

In 2025 Q1–Q4, the median prevailing offer was 6.44x the qualifying payment amount (QPA), with a 25th to 75th percentile range of 3.11x to 10.73x (n = 24,590 line items). This uses the CMS field Prevailing Party Offer as % of QPA, where 1.00x equals the QPA.

How long do Federal IDR decisions take for internal and family medicine?

In 2025 Q1–Q4, the median was 32 business days (n = 25,299 line items), using the CMS field Length of Time to Make Determination (from dispute initiation).

How to Utilize IDR